Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 10.743% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a CCCCC(=O)N=c1sc2cc([N+](=O)[O-])ccc2n1C
b CCC(=O)N1CCN(CCN=CC2=C(O)CC(c3cccs3)CC2=O)CC1
c O=C(NCc1ccccc1)c1ccc(CN2CCC(Cc3ccccc3)CC2)cc1
d Cc1ccc(OCCCSc2ncccn2)cc1C
e CN(C(=O)CSc1nnnn1C)C1(C#N)CCCCC1
Answer: e. CN(C(=O)CSc1nnnn1C)C1(C#N)CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C(=O)CSc1nnnn1C)C1(C#N)CCCCC1
CN(C(=O)CSc1nnnn1C)C1(C#N)CCCCC1
N-(1-cyanocyclohexyl)-N-methyl-2-(1-methyltetrazol-5-yl)sulfanylacetamide